Continuum vaccines provide the following options for vaccination against Leptospira canicola, L. icterohaemorrhagiae, and canine coronavirus:

• Continuum Lepto
  • Description: Continuum Lepto contains inactivated L. canicola and L. icterohaemorrhagiae
  • Indications: For the vaccination of healthy dogs as an aid in the prevention of disease caused by L. canicola and L. icterohaemorrhagiae
• Continuum Corona
  • Description: Continuum Corona is an inactivated virus vaccine presented in a ready-to-use liquid form
  • Indications: For vaccination of healthy dogs as an aid in the prevention of disease associated with canine coronavirus infection
• Continuum Lepto/Corona
  • Description: Continuum Lepto/Corona is an inactivated canine coronavirus and inactivated L. canicola and L. icterohaemorrhagiae vaccine presented in a ready-to-use liquid form
  • Indications: For the vaccination of healthy dogs as an aid in the prevention of disease caused by canine coronavirus, L. canicola, and L. icterohaemorrhagiae

Efficacy and Safety

• The safety, efficacy, and compatibility of each of the components of Continuum Lepto, Continuum Corona, and Continuum Lepto/Corona have been demonstrated to meet or exceed USDA standards

Directions for Use

• Aseptically administer 1 mL subcutaneously in healthy dogs as early as 6 weeks of age and revaccinate every 3-4 weeks until 12 weeks of age
• Vaccinate dogs over 12 weeks of age with two doses 3-4 weeks apart
• Annual revaccination with a single dose is recommended